PPARA and neoplasm: PPARα was found to respond to the fatty acids delivered by tumor-derived exosomes (TDEs), resulting in excess lipid droplet biogenesis and enhanced fatty acid oxidation (FAO), culminating in a metabolic shift toward mitochondrial oxidative phosphorylation, which drives tumor-infiltrating DCs (TIDCs) immune dysfunction (50).